Nivolumab,Ipilimumab
BMS
[]
did cure a majority of #lynchsyndrome patients in this setting? these are incredible data!! #esmo22 
#MedicalOncologist tweeting on #immunotherapy, #drugdevelopment, #COVID19 & #HealthEcon. #NCI #CancerMoonshot Adult Immunotherapy Co-Chair. Tweets are mine.